Generalized autoimmunity of ANCA and ASCA related to severity of disease in autistic children with GI disease

Immunology and Immunogenetics Insights

Volumn 1, Issue 1, 2009, Pages 37-47

  Russo, A J ^a   Krigsman, A ^b   Jepson, B ^b   Wakefield, Andrew ^b  

^a Pfeiffer Treatment Center   (United States)

^b Thoughtful House Center for Children   (United States)

Author keywords

ANCA; ASCA; Autism; Autoimmunity; GI disease

Indexed keywords

SACCHAROMYCES CEREVISIAE;

EID: 84861988911     PISSN: None     EISSN: 11786345     Source Type: Journal    
DOI: 10.4137/iii.s3073     Document Type: Article

References (51)

1. Van der Woude FJ, Rasmussen N, Lobatto S, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. 1985;1(8426):425-9.
2. Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW. Antineutrophil cytoplasmic antibodies: current diagnostic and pathophysiolical potential. Kidney Int. 1994;46:1-15.
3. Kallenberg CGM, Mulder AHL, Cohen Tervaert JW. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med. 1992;93:675-82.
4. Saxon A, Shanahan F, Landers CJ, et al. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol. 1990;86:202-10.
5. Rump JA, Schölmerich J, Gross V, et al. A new type of perinuclear antineutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiol. 1990;181:406-13.
6. Duerr RH, Targan SR, Landers CJ, et al. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterol. 1991;100:1385-91.
7. Mulder AHL, Horst G, Haagsma EB, et al. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatol. 1993;17:411-7.
8. Roozendaal C, Van Milligen de Wit AWM, Haagsma EB, et al. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features. Am J Med. 1998;105:393-9.
9. Lassoued S, Sixou L, Oksman F, et al. Antineutrophil cytoplasmic antibodies and antibodies to myeloperoxidase in rheumatoid arthritis. Arthritis Rheum. 1991;34:1069-70.
10. Mulder AHL, Horst G, Van Leeuwen MA, et al. Anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis: characterization and clinical correlates. Arthritis Rheum. 1993;36:1054-60.
11. Schnabel A, Csernok E, Isenberg DA, et al. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus: prevalence, specificities, and clinical significance. Arthritis Rheum. 1995;38:633-7.
12. Spronk PE, Bootsma H, Horst G, et al. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Br J Rheumatol. 1996;35:625-31.
13. Sutton CL, Yang H, Li Z, et al. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut. 2000;46:58-63.
14. McKay DM. Bacterial superantigens: Provocateurs of gut dysfunction and inflammation. Trends Immunol. 2001;22:497-501.
15. Hoffenberg EJ, Fidanza S, Sauaia A. Serologic testing for inflammatory bowel disease. J Pediatr. 1999;134:447-52.
16. Peeters M, Joossens S, Vermeire S, et al. Diagnostic value of anti- Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol. 2001;96:730-4.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington D.C.: American Psychiatric Association. 1994.
18. Gillberg C, Coleman M. The Biology of the Autistic Syndromes, 2nd edn. London: Mac Keith Press. 1992.
19. Filipek P, Accardo P, Baranek G, et al. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord. 1999;29(6):439-84.
20. Bailey A, Phillips W, Rutter M. Autism: towards an integration of clinical, genetic, neuro-psychological, and neurobiological perspectives. J Child Psychol Psychiatry. 1996;37(1):89-126.
21. Horvath K, Perman J. Autistic disorder and gastrointestinal disease. Curr Opin Pediat. 2002;14:(5):583-7.
22. Molloy C, Manning-Courtney P. Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Autism. 2003;7:(2):165-71.
23. Valicenti-McDermott M, McVicar K, Rapin I. Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. J Dev Behav Pediatr. 2006; 27(Suppl 2):S128-36.
24. Ashwood P. et al. Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J Clin Immunol. 2003 Nov; 23(6):504-17.
25. Balzola F, et al. Autistic enterocolitis: confirmation of a new inflammatory bowel disease in an Italian cohort of patients. Gastroenterology. 2005;128 Suppl 2:A-303.
26. Wakefield AJ, et al. Review article: the concept of entero-colonic encephalopathy, autism and opioid receptor ligands. Aliment Pharmacol Ther. 2002;16(4):663-74.
27. Wakefield AJ, et al. Enterocolitis in children with developmental disorders. Am J Gastroenterol. 2000;95(9):2285-95.
28. Shaw W, Kassen E, Chaves E. Increased urinary excretion of analogs of Krebs cycle metabolites and arabinose in two brothers with autistic features. Clin Chem. 1995;41:1094-104.
29. Shaw W, Kassen E, Chaves E. Assessment of antifungal drug therapy in autism by measurement of suspected microbial metabolites in urine with gas chromatography-mass spectrometry. Clin Pract Alternat Med. 2000;1:15-26.
30. Russo AJ, Krigsman A, Jepson B, Wakefield A. Anti-PR3 and Anti-MPO IgG ANCA in Autistic Children With Chronic GI Disease. Immunology and Immunogenetics Insights. 2009;2:21-8.
31. Russo AJ, Krigsman A, Jepson B, Wakefield A. Low Serum Alpha-1 Antitrypsin Associated With Anti-PR-3 ANCA in Autistic Children With GI Disease, accepted for publication. Genomics Insights. 2009;2:1-9.
32. Trottier G, Srivastava L, Walker CD. Etiology of infantile autism: a review of recent advances in genetic and neurobiological research. J Psychiatry Neurosci. 1999;24(2):103-15.
33. Van Gent T, Heijnen CJ, Treffers PD. Autism and the immune system. J Child Psychol Psychiatry Allied Discip. 1997;38(3):337-49.
34. Singh VK, Warren R, Averett R, Ghaziuddin M. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr Neurol. 1997; 17(1):88-90.
35. Singh VK, Warren RP, Odell JD, Warren WL, Cole P. Antibodies to myelin basic protein in children with autistic behavior. Brain Behav Immun. 1993; 7(1):97-103.
36. Singh VK, Singh EA, Warren RP. Hyperserotoninemia and serotonin receptor antibodies in children with autism but not mental retardation. Biol Psychiatry. 1997;41(6):753-5.
37. Silva SC, Correia C, Fesel C, et al. Autoantibody repertoires to brain tissue in autism nuclear families. J Neuro Immunol. 2004;152(12):176-8.
38. Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol. 1999;14(6):388-94.
39. Sweeten TL, Bowyer SL, Posey DJ, Halberstadt GM, McDougle CJ. Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics. 2003;112(5):e420.
40. Yan J. Autistic Children More Often Have Parent With Mental Illness. Psychiatr News. 2008;43(12):22.
41. Sweeten TL, Bowyer SL, Posey DJ, Halberstadt GM, McDougle CJ. Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics [Serial Online]. 2003;112:e420.
42. Croen LA, Grether JK, Yoshida CK, Oduli R, Van de Water J. Maternal autoimmune diseases, asthma and allergies and childhood autism. Arch Pediatr Adolesc Med. 2004.
43. Cook EH, Leventhal BL. The serotonin system in autism. Curr Opin Pediatr. 1996;8(4):348-54.
44. Cook EH. Autism: review of neurochemical investigation. Synapse. 1990;6(3):292-308.
45. Betancur C, Corbex M, Spielewoy C, et al. Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder. Mol Psychiatry. 2002;7(1):67-71.
46. Todd RD, Ciaranello RD. Demonstration of inter- and intraspecies differences in serotonin binding sites by antibodies from an autistic child. Proc Natl Acad Sci U S A. 1985;82(2):612-6.
47. Rumsey JM, Ernst M. Functional neuroimaging of autistic disorders. Ment Retard Dev Disabil Res Rev. 2000;6(3):171-9.
48. Rosengren LE, Ahlsen G, Belfrage M, Gillberg C, Haglid KG, Hamberger AA. Sensitive ELISA for glial fibrillary acidic protein: application in CSF of children. J Neurosci Methods. 1992;44(2-3):113-9.
49. Torrente F, Ashwood P, Day R, et al. Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry. 2002;7(4):375-82.
50. Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol. 1999;14(6):388-94.
51. Sweeten TL, Bowyer SL, Posey DJ, Halberstadt GM, McDougle CJ. Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics. 2003;112(5):e420.